Efficacy of Levodopa-Carbidopa Intestinal Gel Versus Oral Levodopa-Carbidopa in Advanced Parkinson's: Sensitivity and Responder Analyses

被引：0
|
作者：
Boyd, James T.
Fernandez, Hubert H.
Slevin, John T.
Espay, Alberto J.
Standaert, David G.
Pritchett, Yili
Zhang, Wuyan
Chatamra, Krai
Widnell, Katherine L.
Benesh, Janet
机构：
来源：
ANNALS OF NEUROLOGY | 2013年 / 74卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S44 / S44
页数：1
相关论文
共 50 条
  • [1] Efficacy of levodopa-carbidopa intestinal gel compared to oral levodopa-carbidopa in advanced Parkinson's disease: Sensitivity and responder analyses
    Boyd, J. T.
    Fernandez, H. H.
    Slevin, J. T.
    Espay, A. J.
    Standaert, D. G.
    Pritchett, Y.
    Zhang, W.
    Chatamra, K.
    Widnell, K. L.
    Benesh, J.
    MOVEMENT DISORDERS, 2013, 28 : S143 - S143
  • [2] Levodopa-Carbidopa Intestinal Gel Pharmacokinetics: Lower Variability than Oral Levodopa-Carbidopa
    Othman, Ahmed A.
    Rosebraugh, Matthew
    Chatamra, Krai
    Locke, Charles
    Dutta, Sandeep
    JOURNAL OF PARKINSONS DISEASE, 2017, 7 (02) : 275 - 278
  • [3] Levodopa-carbidopa intestinal gel for advanced Parkinson's disease
    Bohlega S
    Abou Al-Shaar H
    Alkhairallah T
    中华物理医学与康复杂志, 2016, (03) : 179 - 179
  • [4] Efficacy of levodopa-carbidopa intestinal gel in patients with advanced Parkinson's disease: Subgroup analyses
    Standaert, D. G.
    Slevin, J. T.
    Espay, A. J.
    Boyd, J. T.
    Fernandez, H. H.
    Pritchett, Y.
    Zhang, W.
    Chatamra, K.
    Widnell, K. L.
    Benesh, J.
    MOVEMENT DISORDERS, 2013, 28 : S143 - S144
  • [5] Jejunal Infusion of Levodopa-Carbidopa Intestinal Gel Versus Oral Administration of Levodopa-Carbidopa Tablets in Japanese Subjects with Advanced Parkinson's Disease: Pharmacokinetics and Pilot Efficacy and Safety
    Othman, Ahmed A.
    Chatamra, Krai
    Mohamed, Mohamed-Eslam F.
    Dutta, Sandeep
    Benesh, Janet
    Yanagawa, Masayoshi
    Nagai, Masahiro
    CLINICAL PHARMACOKINETICS, 2015, 54 (09) : 975 - 984
  • [6] Efficacy and safety of Levodopa-Carbidopa Intestinal Gel in the treatment of Parkinson's Disease
    Londero, E.
    dos Santos, A. P.
    Braga, R.
    de Barros, R.
    dos Reis, L.
    Freire, G.
    MOVEMENT DISORDERS, 2021, 36 : S220 - S220
  • [7] Effect of levodopa-carbidopa intestinal gel in advanced Parkinson's disease patients
    Takei, T.
    Uozumi, T.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2017, 381 : 742 - 742
  • [8] Continuous infusion of levodopa-carbidopa intestinal gel in Parkinson's disease
    Guthikonda, Lalitha N.
    Lyons, Kelly E.
    Pahwa, Rajesh
    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2014, 3 (04) : 331 - 333
  • [9] Titration of Levodopa-Carbidopa Intestinal Gel in US Patients with Advanced Parkinson's Disease
    Aldred, Jason
    Davis, Thomas
    Zamudio, Jorge
    Kukreja, Pavnit
    Bergmann, Lars
    Li, Mei
    Standaert, David
    MOVEMENT DISORDERS, 2018, 33 : S93 - S93
  • [10] Patient and caregiver outcomes with levodopa-carbidopa intestinal gel in advanced Parkinson's disease
    Valldeoriola, Francesc
    Jose Catalan, Maria
    Escamilla-Sevilla, Francisco
    Freire, Eric
    Olivares, Jesus
    Cubo, Esther
    Santos Garcia, Diego
    Calopa, Matilde
    Martinez-Martin, Pablo
    Carlos Parra, Juan
    Arroyo, Gloria
    Matias Arbelo, Jose
    NPJ PARKINSONS DISEASE, 2021, 7 (01)
12345